| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $118.54 | $23.68 | 400.53% | 223.66x | 56.42x | 15.04x | 18.16x | 1.62x | $106.92M | 0.86% | $705.78M | 6.70 | $12.71B | 1,620.44 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $24.49 | $8.09 | 202.69% | 116.62x | 54.75x | 6.89x | 13.96x | 1.00x | $39.15M | 1.22% | $220.58M | 1.69 | $3.16B | 69.57 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $224.53 | $79.27 | 183.25% | 36.81x | 33.30x | 6.24x | 22.19x | 1.27x | $793.95M | 2.65% | $1.35B | 10.14 | $31.32B | 26.56 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.75 | $17.06 | 361.55% | 73.60x | 67.37x | 7.27x | 9.39x | 1.88x | $182.84M | 2.99% | $654.15M | 8.43 | $5.98B | 49.83 | ||
| KRYS | KRYSTAL BIOTECH INC | $327.30 | $82.71 | 295.70% | 39.58x | 41.93x | 21.94x | 7.13x | 2.11x | $257.78M | 2.67% | $1.36B | 46.03 | $9.27B | 39.73 | ||
| HALO | HALOZYME THERAPEUTICS INC | $109.84 | $70.10 | 56.69% | 30.85x | 12.16x | 7.74x | 86.85x | 0.59x | $806.22M | 6.26% | $143.54M | 1.22 | $14.45B | 20.11 | ||
| VCEL | VERICEL CORP | $40.05 | $7.88 | 408.50% | 83.44x | 71.56x | 6.68x | 5.54x | 2.05x | $61.66M | 3.01% | $370.04M | 7.25 | $2.02B | 45.81 | ||
| RPRX | ROYALTY PHARMA PLC | $56.21 | $35.64 | 57.71% | 29.90x | 10.28x | 9.86x | 3.30x | 0.60x | $2.92B | 11.69% | $9.79B | 21.99 | $40.47B | 34.41 | ||
| TGTX | TG THERAPEUTICS INC | $53.34 | $22.09 | 141.51% | 17.32x | 53.67x | 9.46x | 13.52x | 1.93x | $17.39M | 0.23% | $604.08M | 4.26 | $8.43B | 60.58 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.00 | $7.50 | 46.71% | 11.58x | 10.11x | 4.78x | 3.00x | 1.01x | $82.01M | 12.60% | $217.65M | 3.68 | $509.40M | 6.59 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.89 | $18.36 | 199.00% | 144.45x | 18.97x | 3.12x | 1.68x | 0.96x | $738.18M | 6.95% | $6.32B | 32.68 | $13.94B | 36.14 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $222.45 | $177.59 | 25.26% | 14.58x | 8.70x | 3.06x | 3.01x | 0.60x | $1.62B | 11.52% | $4.80B | 75.98 | $17.22B | 10.65 | ||
| EXEL | EXELIXIS INC | $59.02 | $29.56 | 99.67% | 17.94x | 17.84x | 6.08x | 7.93x | 1.18x | $1.17B | 7.92% | $1.84B | 7.35 | $14.51B | 13.34 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $295.00 | $84.58 | 248.79% | 29.29x | 31.23x | 20.37x | 6.08x | 2.22x | $130.62M | 2.21% | $967.52M | 48.22 | $6.01B | 21.53 | ||
| MDXG | MIMEDX GROUP INC | $4.62 | $1.25 | 268.35% | 115.50x | -26.64x | 1.92x | 3.12x | 1.25x | $44.50M | 6.52% | $216.00M | 1.46 | $554.78M | 24.32 | ||
| ADMA | ADMA BIOLOGICS INC | $10.33 | $6.87 | 50.27% | 14.35x | 12.98x | 4.60x | 5.67x | 0.84x | $116.47M | 4.94% | $408.21M | 1.79 | $2.38B | 10.20 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $503.25 | $146.16 | 244.30% | 29.04x | 26.29x | 10.14x | 6.30x | 2.18x | $3.80B | 2.97% | $20.25B | 79.81 | $123.39B | 22.42 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.60 | $29.65 | 33.57% | 12.61x | 9.50x | 2.39x | 2.31x | 0.75x | $354.90M | 15.47% | $999.24M | 17.25 | $1.91B | 6.82 | ||
| UTHR | UNITED THERAPEUTICS CORP | $532.78 | $185.82 | 186.71% | 17.62x | 19.94x | 7.19x | 3.57x | 3.23x | $1.09B | 4.82% | $6.40B | 150.24 | $21.05B | 12.55 | ||
| TECH | BIO-TECHNE CORP | $72.45 | $16.04 | 351.63% | 61.92x | 34.87x | 9.30x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.39B | 32.75 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $739.57 | $421.56 | 75.44% | 17.63x | 13.18x | 4.89x | 2.40x | 0.93x | $3.76B | 4.95% | $31.71B | 308.48 | $76.39B | 13.29 | ||
| VCYT | VERACYTE INC | $43.60 | $11.55 | 277.37% | 30.28x | 22.42x | 6.21x | 2.52x | 2.54x | $165.99M | 4.76% | $1.39B | 17.36 | $3.24B | 23.22 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.14 | $1.37 | -16.63% | 8.14x | -2.57x | 1.41x | 1.50x | 0.45x | $19.58M | 29.65% | $44.20M | 0.76 | $17.66M | 2.31 | ||
| INCY | INCYTE CORP | $112.75 | $58.03 | 94.28% | 13.89x | 31.80x | 3.88x | 3.60x | 1.56x | $1.92B | 8.50% | $6.34B | 31.66 | $18.90B | 9.14 |